127 related articles for article (PubMed ID: 33093896)
1. Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas.
Deng S; Fan Z; Gong Y; Cheng H; Jin K; Qian Y; Xiao Z; Liu Y; Wang R; Zheng Y; Ni Q; Yu X; Liu C; Luo G
Exp Ther Med; 2020 Dec; 20(6):158. PubMed ID: 33093896
[TBL] [Abstract][Full Text] [Related]
2. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas.
Sun LQ; Peng LS; Guo JF; Jiang F; Cui F; Huang HJ; Jin ZD
World J Gastroenterol; 2021 Feb; 27(6):501-512. PubMed ID: 33642824
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
4. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.
Fang T; Wang H; Wang Y; Lin X; Cui Y; Wang Z
Dis Markers; 2019; 2019():6016931. PubMed ID: 30863466
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis and prognosis factors of malignancy in the patients with mucinous cystic neoplasms of the pancreas].
Li WL; Xu YD; Han X; Wu WC; Lou WH;
Zhonghua Wai Ke Za Zhi; 2020 Mar; 58(3):225-229. PubMed ID: 32187927
[No Abstract] [Full Text] [Related]
7. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
8. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
[TBL] [Abstract][Full Text] [Related]
9. Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography-guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms.
Zhan XB; Wang B; Liu F; Ye XF; Jin ZD; Li ZS
J Dig Dis; 2013 Apr; 14(4):191-5. PubMed ID: 23280287
[TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis.
Wang W; Zhang L; Chen L; Wei J; Sun Q; Xie Q; Zhou X; Zhou D; Huang P; Yang Q; Xie H; Zhou L; Zheng S
Biomed Rep; 2015 Jan; 3(1):43-50. PubMed ID: 25469245
[TBL] [Abstract][Full Text] [Related]
11. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
13. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.
Gaddam S; Ge PS; Keach JW; Mullady D; Fukami N; Edmundowicz SA; Azar RR; Shah RJ; Murad FM; Kushnir VM; Watson RR; Ghassemi KF; Sedarat A; Komanduri S; Jaiyeola DM; Brauer BC; Yen RD; Amateau SK; Hosford L; Hollander T; Donahue TR; Schulick RD; Edil BH; McCarter M; Gajdos C; Attwell A; Muthusamy VR; Early DS; Wani S
Gastrointest Endosc; 2015 Dec; 82(6):1060-9. PubMed ID: 26077458
[TBL] [Abstract][Full Text] [Related]
15. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients?
Park JW; Jang JY; Kang MJ; Kwon W; Chang YR; Kim SW
Pancreatology; 2014; 14(2):131-6. PubMed ID: 24650968
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
17. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the Probability of Malignancy in Mucinous Cystic Neoplasm of the Pancreas With Ovarian-Type Stroma: A Nationwide Multicenter Study in Japan.
Ohtsuka T; Nakamura M; Hijioka S; Shimizu Y; Unno M; Tanabe M; Nagakawa Y; Takaori K; Hirono S; Gotohda N; Kimura W; Ito K; Katanuma A; Sano T; Urata T; Kita E; Hanada K; Tada M; Aoki T; Serikawa M; Okamoto K; Isayama H; Gotoh Y; Ishigami K; Yamaguchi H; Yamao K; Sugiyama M; Okazaki K
Pancreas; 2020 Feb; 49(2):181-186. PubMed ID: 32011526
[TBL] [Abstract][Full Text] [Related]
19. Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Huang G; Chen R; Lu N; Chen Q; Lv W; Li B
Onco Targets Ther; 2020; 13():5155-5164. PubMed ID: 32606736
[TBL] [Abstract][Full Text] [Related]
20. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
